Clinical Trial: Clinical features and mechanisms of thrombocytopenia induced by immune checkpoint inhibitors in cancer patients. (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical features and mechanisms of thrombocytopenia induced by immune checkpoint inhibitors in cancer patients.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134175

Registration Time: 2026/10/12

Type: Observational study

Primary Sponsor: Zhongshan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=240641

Published by HT Digital Content Services with permission from Health Daily Digest....